A Phase III, Randomized Trial of Weekly Cisplatin and Radiation Versus Cisplatin and Tirapazamine (IND #46525) and Radiation in Stage IB2, IIA, IIIB and IVA Cervical Carcinoma Limited to the Pelvis
Phase of Trial: Phase III
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Tirapazamine (Primary) ; Cisplatin
- Indications Cervical cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 Jul 2017 Status changed from completed to discontinued.
- 02 Dec 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.